Fundz

Elucid Appoints Dr. Robert Pelberg as Senior Vice President of Medical Affairs

PRIVATEJul 07, 2025

Position

Senior Vice President

Company

Elucid

Robert Pelberg
robert.pelberg@elucid.com
BostonManufacturingHealth Care

Description

Elucid has named Dr. Robert Pelberg as its new senior vice president of medical affairs. He will lead the company's clinical operations quality efforts and help shape its clinical and research strategies.

Quick answer

Elucid Appoints Dr. Robert Pelberg as Senior Vice President of Medical Affairs (July 7, 2025). Elucid is based in Boston, Massachusetts, United States.

Who is the new Senior Vice President at Elucid?
Elucid named Robert Pelberg Senior Vice President, announced July 7, 2025.
What did Elucid announce on July 7, 2025?
Elucid has named Dr. Robert Pelberg as its new senior vice president of medical affairs. He will lead the company's clinical operations quality efforts and help shape its clinical and research strategies.
What does Elucid do?
Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease.
Where is Elucid based?
Elucid is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Bard (July 7, 2025), ViaLase (July 8, 2025), Merit Medical Systems  Inc (July 8, 2025) and Jazz Pharmaceuticals plc (July 10, 2025) also announced leadership changes within 45 days of Elucid.

Source: Fundz verified event record.

Other recent leadership changes in Manufacturing and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Elucid, and when

A new leader at Elucid brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Elucid raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elucid, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elucid. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elucid

Location

Boston, Massachusetts, United States

About

Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elucid changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Windi
Likely contact at this company
••••••••@••••••••

See Windi's verified email →

Robert
Likely contact at this company
••••••••@••••••••

See Robert's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Elucid's next move

Learn about Strategic plan

Elucid changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.